ReviewBME frontiers2025
Microbial Siderophores: A New Insight on Healthcare Applications.
Review in BME frontiers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Kineochelins-A New Group of Siderophores From an Antarctic Bacterium.Microbial biotechnology · 2026Article
- Bacterial Siderophore Production in Metal-Rich Environments: Underexplored Sources of Siderophores and Insights into Bioremediation.Journal of natural products · 2026Review
- Injectable deferoxamine-loaded microsphere hydrogels for inhibition of ferroptosis and promotion of third-degree burn wound healing.Materials today. Bio · 2025Article
- The Role of Bacterial Siderophores in Infection Therapy: From Anti-Infective Mechanisms to Therapeutic Advances.International journal of nanomedicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, increased illness and disorders have gained importance in improvising therapeutics to help extend the lifespan of an individual. In this scenario, understanding the mechanism of bacterial pathogenicity linked to the interaction between the host and the pathogen focusing on essential metal ions is necessary. Numerous studies indicate that the severity of a disease might be due to the reduced availability of iron, linked to abnormal production or lack of acquisition systems. However, several microbes produce siderophores as virulence factors, low-molecular-weight organic compounds for acquisition of iron by iron-chelating systems. In medical applications, siderophores are employed in novel strategies in order to design effective new drugs and vaccines, targeting and delivering antibiotics to target sites in multidrug-resistant pathogens. Meanwhile, some types of siderophores are used as drug delivery modalities and antimalarial, anticancer, and antibacterial agents, for example, by employing conjugation techniques such as Trojan horse delivery. Hence, the current review integrates several applications of siderophores with an overview covering taxonomy, organisms producing iron affinity carriers, and their acquisition mechanism. This understanding may delineate newer opportunities to adapt possible therapies and/or treatments against several multidrug-resistant pathogens, representing a crucial solution for public health problems worldwide.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.